Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dorado, PR
SEC filing record 1 source field available
Fiscal year end
31 October
Pharma-Bio Serv, Inc. has filed 524 SEC EDGAR filings since 24 Sep 2004

SEC filing history

Showing 176-200 of 373 matching filings.

Per page
25
Current page
8
8-K File 000-50956

CURRENT REPORT

Filing date
29 Jun 2018
Reporting date
29 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
14 Jun 2018
Reporting date
14 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
14 Jun 2018
Reporting date
30 Apr 2018
Next action
Verify source filing
DEF 14A File 000-50956

PRIMARY DOCUMENT

Filing date
25 May 2018
Reporting date
29 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
19 Mar 2018
Reporting date
19 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
19 Mar 2018
Reporting date
31 Jan 2018
Next action
Verify source filing
10-K/A File 000-50956

AMENDMENT NO. 1

Filing date
28 Feb 2018
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
30 Jan 2018
Reporting date
29 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-50956

ANNUAL REPORT

Filing date
29 Jan 2018
Reporting date
31 Oct 2017
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2018
Reporting date
10 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2018
Reporting date
10 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Jan 2018
Reporting date
10 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2018
Reporting date
10 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
28 Sep 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
14 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
14 Sep 2017
Reporting date
31 Jul 2017
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
14 Jun 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
14 Jun 2017
Reporting date
30 Apr 2017
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
31 May 2017
Reporting date
26 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50956

DEFINITIVE PROXY STATEMENT

Filing date
26 Apr 2017
Reporting date
26 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50956

CURRENT REPORT

Filing date
17 Mar 2017
Reporting date
17 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-50956

QUARTERLY REPORT

Filing date
17 Mar 2017
Reporting date
31 Jan 2017
Next action
Verify source filing
10-K/A File 000-50956

10K/A

Filing date
28 Feb 2017
Reporting date
31 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-50956

ANNUAL REPORT

Filing date
31 Jan 2017
Reporting date
31 Oct 2016
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .